Spread of extensively drug-resistant tuberculosis in Kwazulu-Natal Province, South Africa

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Moodley, Prashini ^a,b   Shah, N Sarita ^a,c,d   Tayob, Nabihah ^e   Connolly, Cathy ^e   Zetola, Nicola ^f   Gandhi, Neel ^a,c,d   Friedland, Gerald ^a,d,g   Sturm, A Willem ^a,b  

^a AFRICA HEALTH RESEARCH INSTITUTE   (South Africa)

^b KwaZulu Natal Department of Health   (South Africa)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d Tugela Ferry   (South Africa)

^e SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; KANAMYCIN; OFLOXACIN; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL TRANSMISSION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; POPULATION DENSITY; SOUTH AFRICA; SPUTUM CULTURE; MICROBIOLOGICAL EXAMINATION;

MYCOBACTERIUM TUBERCULOSIS;

ANTITUBERCULAR AGENTS; CROSS-SECTIONAL STUDIES; ETHAMBUTOL; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HUMANS; ISONIAZID; KANAMYCIN; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; RIFAMPIN; SOUTH AFRICA; STREPTOMYCIN;

EID: 79957834340     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017513     Document Type: Article

References (9)

1. World Health Organization (2009) Global tuberculosis control- epidemiology, strategy, financing: WHO report 2009. Geneva, Switzerland; Report No: WHO/HTM/TB/2009.411.
2. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, et al. (2006) Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368: 1575-1580.
3. Statistical Release P0302 (2003) Statistics South Africa. Available: http://www.statssa.gov.za/publications/P0302/P03022003.pdf. Accessed 2011 Mar 20.
4. Department of Health South Africa (2007) National HIV and Syphilis Prevalence Survey in South Africa, 2006 Report. Available: http://www.doh.gov.za/docs/reports/2007/hiv/part1.pdf. Accessed 2011 March 20.
5. Hacek D, (1992) Modified Proportion Agar Dilution Test for slowly growing Mycobacteria. In: Isenberg HD, editors. Clinical Microbiology Procedures Handbook pp. 5.13.1-15 AMS: volume 1.
6. Weyer K, Lancaster J, Brand J, van der Walt M, Levin J, (2003) Survey of Tuberculosis Drug Resistance in South Africa 2001-2002. Medical Research Council Unit for TB Epidemiology and Interventions Branch, Pretoria.
7. Pillay M, Sturm AW, (2007) Evolution of the extensively drug-resistant F15/LAM4/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa. Clin Infect Dis 45: 1409-1414.
8. Ioerger TR, Koo S, No EG, Chen X, Larsen MH, et al. (2009) Genome Analysis of multi- and extensively-drug resistant tuberculosis from KwaZulu-Natal, South Africa. PLoS One 4 (11): e7778.
9. Harrison D, (2009) Report: An Overview of Health and Health care in South Africa 1994-2010: Priorities, Progress and Prospects for New Gains. Available: http://www.doh.gov.za/docs/reports/2010/overview1994-2010.pdf. Accessed 2011 Mar 20.